药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bitolterol
Zaleplon
Cefepime may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Bitolterol
Mepivacaine
Cefepime may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
Bitolterol
Pindolol
Cefepime may decrease the excretion rate of Pindolol which could result in a higher serum level.
Bitolterol
Rizatriptan
Cefepime may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Bitolterol
Isoniazid
Cefepime may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Bitolterol
Maprotiline
Cefepime may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Bitolterol
Azacitidine
Cefepime may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Bitolterol
Almotriptan
Cefepime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Bitolterol
Incadronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefepime is combined with Incadronic acid.
Bitolterol
Tiludronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefepime is combined with Tiludronic acid.
Bitolterol
Etidronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefepime is combined with Etidronic acid.
Bitolterol
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Cefepime.
Bitolterol
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Cefepime.
Bitolterol
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Hygromycin B.
Bitolterol
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Dihydrostreptomycin.
Bitolterol
Puromycin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Puromycin.
Bitolterol
Neamine
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Neamine.
Bitolterol
Apramycin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Apramycin.
Bitolterol
Geneticin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Geneticin.
Bitolterol
Paromomycin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Paromomycin.